Caveolin-1 is required for signaling and membrane targeting or EphB1 receptor tyrosine kinase

Journal of Cell Science

Volumn 119, Issue 11, 2006, Pages 2299-2309

  Vihanto, Meri M ^a   Vindis, Cecile ^a,d   Djonov, Valentin ^b   Cerretti, Douglas P ^c   Huynh Do, Uyen ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c AMGEN INC   (United States)

^d CHU RANGUEIL   (France)

Author keywords

Caveolae; Caveolin 1; Eph receptors; Ephrins; Signaling; Targeting

Indexed keywords

AMINO ACID; CAVEOLIN 1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR B1; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; PROTEIN TYROSINE KINASE; STRUCTURAL PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CAVEOLA; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CAVEOLIN 1; CELL LINE, TUMOR; CELL MEMBRANE; CERCOPITHECUS AETHIOPS; CHO CELLS; CHOLESTEROL; COS CELLS; CRICETINAE; EPHRIN-B2; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; PHOSPHORYLATION; PROTEIN TRANSPORT; RECEPTOR, EPHA2; RECEPTOR, EPHB1; SIGNAL TRANSDUCTION;

EID: 33745494465     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02946     Document Type: Article

References (63)

1. Bauer, P. M., Yu, J., Chen, Y., Hickey, R., Bernatchez P. N., Looft-Wilson, R., Huang, Y., Giordano, F., Stan, R. V. and Sessa, W. C. (2005). Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc. Natl. Acad Sci. USA 102, 204-209.
2. Brantley, D. M., Cheng, N., Thompson, E. J., Lin, Q., Brekken, R. A., Thorpe, P. E., Muraoka, R. S., Cerretti, D. P., Pozzi, A., Jackson, D. et al. (2002). Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21, 7011-7026.
3. Brown, D. A. and London, E. (1998). Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111-136.
4. Chang, W. J., Rothberg, K. G., Kamen, B. A. and Anderson, R. G. (1992). Lowering the cholesterol content of MA104 cells inhibits receptor-mediated transport of folate. J. Cell Bial. 118, 63-69.
5. Christian, A. E., Haynes, M. P., Phillips, M. C. and Rothblat, G. H. (1997). Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38, 2264-2272.
6. Couet, J., Li, S., Okamoto, T., Ikezu, T. and Lisanti, M. P. (1997a). Identification of pepfide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 272, 6525-6533.
7. Couet, J., Sargiacomo, M. and Lisanti, M. P. (1997b). Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272, 30429-30438.
8. Dobrzanski, P., Hunter, K., Jones-Bolin, S., Chang, H., Robinson, C., Pritchard, S., Zhao, H. and Ruggeri, B. (2004). Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. Cancer Res. 64, 910-919.
9. Drab, M., Verkade, P., Elger, M., Kasper, M., Lohn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C. et al. (2001). Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293, 2449-2452.
10. Engelman, J. A., Chu, C., Lin, A., Jo, H., Ikezu, T., Okamoto, T., Kohtz, D. S. and Lisanti, M. P. (1998). Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428, 205-211.
11. Esser, S., Wolburg, K., Wolburg, H., Breier, G., Kurzchalia, T. and Risau, W. (1998). Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140, 947-959.
12. Feron, O. and Kelly, R. A. (2001). The caveolar paradox: suppressing, inducing, and terminating eNOS signaling. Circ. Res. 88, 129-131.
13. Fielding, P. E. and Fielding, C. J. (1995). Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 34, 14288-14292.
14. Folkman, J. (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31.
15. Fujioka, K., Azuma, N., Kito, H., Gahtan, V., Esato, K. and Sumpio, B. E. (2000). Role of caveofin in hemodynamic force-mediated endothelial changes. J. Surg. Res. 92, 7-10.
16. Furuchi, T. and Anderson, R. G. (1998). Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J. Biol. Chem. 273, 21099-21104.
17. Galbiati, F., Volonte, D., Engelman, J. A., Watanabe, G., Burk, R., Pestell, R. G. and Lisanti, M. P. (1998). Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascade. EMBO J. 17, 6633-6648.
18. Gale, N. W. and Yancopoulos, G. D. (1999). Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev. 13, 1055-1066.
19. Garcia-Cardena, G., Fan, R., Stern, D. F., Liu, J. and Sessa, W. C. (1996). Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J. Biol. Chem. 271, 27237-27240.
20. Gauthier, L. R. and Robbins, S. M. (2003). Ephrin signaling: one raft to rule them all? One raft to sort them? One raft to spred their call and in signaling bind them? Life Sci. 74, 207-216.
21. Hua, H., Munk, S. and Whiteside, C. I. (2003). Endothelin-1 activates mesangial cell ERK1/2 via EGF-receptor transactivation and caveolin-1 interaction. Am J. Physiol. Renal Physiol. 284, F303-F312.
22. Kim, Y. N., Wiepz, G. J., Guadarrama, A. G. and Bertics, P. J. (2000). Epidermal growth factor-stimulated tyrosine phosphorylation of caveolin- 1. Enhanced caveolin-1 tyrosine phosphorylation following aberrant epidermal growth factor receptor status. J. Biol. Chem 275, 7481-7491.
23. Kimura, A., Mora, S., Shigematsu, S., Pessin, J. E. and Saltiel, A. R. (2002). The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. J. Biol. Chem 277, 30153-30158.
24. Kullander, K. and Klein, R. (2002). Mechanisms and functions of Eph and ephrin signalling. Nat. Rev. Mol. Cell Biol. 3, 475-486.
25. Kurzchalia, T. V. and Parton, R. G. (1999). Membrane microdomains and caveolae. Curr. Opin. Cell Biol. 11, 424-431.
26. Labrecque, L., Royal, I., Surprenant, D. S., Patterson, C., Gingras, D. and Beliveau, R. (2003). Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol. Mol. Biol. Cell 14, 334-347.
27. Lee, H., Volome, D., Galbiati, F., Iyengar, P., Lublin, D. M., Bregman, D. B., Wilson, M. T., Campos-Gonzalez, R., Bouzahzah, B., Pestell, R. G. et al. (2000). Constitutive and growth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol. 14, 1750-1775.
28. Li, S., Okamoto, T., Chun, M., Sargiacomo, M., Casanova, J. E., Hansen, S. H., Nishimoto, I. and Lisanti, M. P. (1995). Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J. Biol. Chem 270, 15693-15701.
29. Li, S., Seitz, R. and Lisanti, M. P. (I 996a). Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J. Biol. Chem 271, 3863-3868.
30. Li, S, Song, K. S. and Lisanti, M. P. (1996b). Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J. Biol. Chem 271, 568-573.
31. Lisanti, M. P., Scherer, P. E., Vidugiriene, J., Tang, Z., Hermanowski-Vosatka, A., Tu, Y. H., Cook, R. F. and Sargiacomo, M. (1994). Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: implications for human disease. J. Cell Biol. 126, 111-126.
32. Liu, P., Ying, Y., Ko, Y. G. and Anderson, R. G. W. (1996). Localization of platelet-derived growth factor-stimulated phosphorylation cascade to caveolae. J. Biol. Chem. 271, 10299-10303.
33. Liu, J., Razani, B., Tang, S., Terman, B. I., Ware, J. A. and Lisanti, M. P. (1999). Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolaeformationin vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J. Biol. Chem 274, 15781-15785.
34. Mao, W., Luis, E., Ross S., Silva, J., Tan, C., Crowley, C., Chui, C., Franz, G., Senter, P., Koeppen, H. et al. (2004). EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer. Cancer Res. 64, 781-788.
35. Mastick, C. C. and Saltiel, A. R. (1997). Insulin-stimulated tyrosine phosphorylation of caveolin is specific for the differentiated adipocyte phenotype in 3T3-L1 cells. J. Biol. Chem 272, 20706-20714.
36. Mineo, C., James, G. L., Smart, E. J. and Anderson, R. G. (1996). Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J. Biol. Chem. 271, 11930-11935.
37. Nawrocki, A. R., Goldring, C. E., Kostadinova, R. M., Frey, F. J. and Frey, B. M. (2002). In vivo footprinting of the human 11beta-hydroxysteroid dehydrogenase type 2 promoter evidence for cell-specific regulation by Sp1 and Sp3. J. Biol. Chem. 277, 14647-14656.
38. Nystrom, F. H., Chen, H., Cong, L. N., Li, Y. and Quon, M. J. (1999). Caveotin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol. Endocrinol. 13, 2013-2024.
39. Okamoto, T., Schlegel, A., Scherer, P. E. and Lisanti, M. P. (1998). Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273, 5419-5422.
40. Parpal, S., Karlsson, M., Thorn, H. and Stralfors, P. (2001). Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J. Biol. Chem. 276, 9670-9678.
41. Prinetti, A., Prioni S., Chigorno, V., Karagogeos, D., Tettamanti, G. and Sonnino, S. (2001). Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by ganglioside monoclonal antibody. J. Neurochem, 78, 1162-1167.
42. Razandi, M, Alton, G., Pedram, A., Ghonshani, S., Webb, P. and Levin, E. R. (2003). Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane. Mol. Cell. Biol. 23, 1633-1646.
43. Razani, B., Engelman, J. A., Wang, X. B., Schubert, W., Zhang, X. L., Marks, C. B., Macaluso, F., Russell, R. G., Li, M., Pestell, R. G. et al. (2001). Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276, 38121-38138.
44. Razani, B., Woodman, S. E. and Lisanti, M. P. (2002). Caveolae: from cell biology to animal physiology. Pharmacol. Rev. 54, 431-467.
45. Resh, M. D. and Erikson, R. L. (1985). Highly specific antibody to Rous sarcoma virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules. J. Cell Biol. 100, 409-417.
46. Schnitzer, J. E., Oh, P., Pinney, E. and Allard, J. (1994). Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127, 1217-1232.
47. Schnitzer, J. E., Oh, P. and McIntosh, D. P. (1996). Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 274, 239-242.
48. Shaul, P. W. and Anderson, R. G. (1998). Role of plasmalemmal caveolae in signal transduction. Am. J. Physiol. 275, L843-L851.
49. Smart, E. J., Ying, Y., Danzell, W. C. and Anderson, R. G. (1996). A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane. J. Biol. Chem. 271, 29427-29435.
50. Song, K. S., Li, S., Okamoto, T., Quilliam, L. A., Sargiacomo, M. and Lisanti, M. P. (1996a). Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. J. Biol. Chem. 271, 9690-9697.
51. Song, K. S., Scherer, P. E, Tang, Z., Okamoto, T., Li, S., Chafel, M., Chu, C., Kohtz, D. S. and Lisanti, M. P. (1996b). Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem. 271, 15160-15165.
52. Stein, E., Huynh-Do, U., Lane, A. A., Cerretti, D. P. and Daniel, T. O. (1998). Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase. J. Biol. Chem. 273, 1303-1308.
53. Tanaka, T. and Kurth, R. (1984). Monoclonal antibodies specific for the avian sarcoma virus transforming protein pp60src. Virology 133, 202-210.
54. Ushio-Fukai, M., Hilenski, L., Santanam, N., Becker, P. L., Ma, Y., Griendling, K. K. and Alexander, R. W. (2001). Cholesterol depletion inhibits epidermal growth factor receptor transactivation by Angiotensin II in vascular smooth muscle cells. Role of Cholesterol-rich microdomains and focal adhesions in Angiotensin II signaling. J. Biol. Chem. 276, 48269-48275.
55. van Deurs, B., Roepstorff, K., Hommelgaard, A. M. and Sandvig, K. (2003). Caveolae: anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol. 13, 92-100.
56. Vihanto, M. M., Plock, J., Erni, D., Frey, B. M., Frey, F. J. and Huynh-Do, U. (2005). Hypoxia upregulates expression of Eph receptors and cphrins in mouse skin. FASEB J. 19, 1689-1691.
57. Vindis, C., Cerretti, D. P., Daniel, T. O. and Huynh-Do, U. (2003). EphB1 recruits c-Src and p52Shc to activate MAPK/ERK and promote chemotaxis. J. Cell Biol. 162, 661-671.
58. Vindis, C., Teli, T., Cerretti, D. P., Turner, C. E. and Huynh-Do, U. (2004). EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. J. Biol. Chem. 279, 27965-27970.
59. Willingham, M. C., Jay, G. and Poston, I. (1979). Localization of the ASV src gene product to the plasma membrane of transformed cells by electron microscopic immunocytochemistry. Cell. 18, 125-134.
60. Yamamoto, M., Toya, Y., Schwencke, C., Lisanti, M. P., Myers, M. G., Jr and Ishikawa, Y. (1998). Caveolin is an activator of insulin receptor signaling. J. Biol. Chem. 273, 26962-26968.
61. Yamamoto, M., Toya, Y., Jensen, R. A. and Ishikawa, Y. (1999). Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell Res. 247, 380-388.
62. Yancey, P. G., Rodrigueza, W. V., Kilsdonk, E. P. C., Stoudt, G. W., Johnson, W. J., Phillips, M. C. and Rothblat, G. H. (1996). Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem 271, 16026-16034.
63. Zeidan, A., Broman, J., Hellstrand, P. and Swärd, K. (2003). Cholesterol dependence vascular ERK1/2 activation and growth in response to stretch. Arterioscler. Thromb. Vasc. Biol. 23, 1528-1534.